Page last updated: 2024-11-06

bistris

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bistris (bis-tris propane) is a zwitterionic buffer commonly used in biochemical and biological research. It is synthesized by reacting tris(hydroxymethyl)aminomethane (Tris) with propane-1,3-diol. Bistris is a good buffer for many applications because it has a high buffering capacity over a wide pH range (pH 6.0-7.5), and it is relatively non-toxic. It is also a good choice for studying enzymatic reactions because it does not interact strongly with most enzymes. Bistris is often used in protein crystallization and purification, as well as in cell culture and other biological assays. Its importance lies in its versatility and effectiveness as a buffer, enabling accurate and reliable experimental results in various biological contexts.'

Bistris: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID81462
CHEBI ID41250
SCHEMBL ID35757
MeSH IDM0086490

Synonyms (62)

Synonym
unii-q1xc3631cp
einecs 230-237-7
q1xc3631cp ,
2-(bis(2-hydroxyethyl)amino))-2-hydroxymethyl-1,3-propanediol
2-(bis(2-hydroxyethyl)amino)-2-(hydroxymethyl)propane-1,3-diol
nsc 119932
1,3-propanediol, 2-(bis(2-hydroxyethyl)amino)-2-(hydroxymethyl)-
nsc 24868
bistris
6976-37-0
nsc119932
1, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)-
2-[bis(2-hydroxyethyl)amino)]-2-hydroxymethyl-1,3-propanediol
nsc-119932
nsc24868
nsc-24868
2-[bis-(2-hydroxy-ethyl)-amino]-2-hydroxymethyl-propane-1,3-diol
bis-tris, bioxtra, >=98.0% (titration)
bis-tris, >=98.0% (titration)
bis-tris, bioperformance certified, cell culture tested, suitable for insect cell culture, >=98.0%
2,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol
bis-tris ,
CHEBI:41250 ,
2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol
bis-2-hydroxy-imino-tris-hydroxymethyl-methane
2-(bis(2-hydroxyethyl)amino)-2-(hydroxymethyl)-1,3-propanediol
bis-tris buffer
bis-tris, bioultra, >=99.0% (nt)
bis(2-hydroxyethyl)aminotris(hydroxymethyl)methane
B1493 ,
bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane bis-tris
AKOS015964206
FT-0609185
EPITOPE ID:161731
bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane ,
BP-20533
1,3-propanediol, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)-
SCHEMBL35757
DTXSID6064537
2,2-bishydroxymethyl-2,2',2''-nitriloethanol
2,2-bis[hydroxymethyl]-2,2',2''-nitrilotriethanol
bis(2-hydroxyethyl)-(iminotris)hydroxymethyl)methane
2-[bis(2-hydroxyethyl)imino]-2-(hydroxymethyl)-1,3-propanediol
bis-(2-hydroxyethyl)aminotris(hydroxymethyl)methane
2,2 - bis(hydroxyethyl)-(iminotris)-(hydroxymethyl)methane
bis-hydroxyethyl tromethamine [inci]
mfcd00002853
sr-01000883740
SR-01000883740-1
bis-tris, >=98%
bis-tris, bioxtra, >=99.0% (nt)
CS-0015166
bis-tris, vetec(tm) reagent grade, >=98%, rnase and dnase free
bis-tris, anhydrous, free-flowing, redi-dri(tm), >=98.0%
SY012935
Q865956
bistris; nsc 119932; nsc 24868; nupage bis-tris
AMY26987
D70475
SB78428
bis-hydroxyethyl tromethamine
HY-D0856
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
bufferAny substance or mixture of substances that, in solution (typically aqueous), resists change in pH upon addition of small amounts of acid or base.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
pentolA polyol with five hydroxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (23.81)18.7374
1990's3 (14.29)18.2507
2000's8 (38.10)29.6817
2010's5 (23.81)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.98 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index85.50 (26.88)
Search Engine Supply Index2.11 (0.95)

This Compound (52.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]